Your browser doesn't support javascript.
loading
Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India.
Chakrabarti, Sasanka; Chakrabarti, Sankha Shubhra; Chandan, Gourav; Kaur, Upinder; Agrawal, Bimal Kumar.
Affiliation
  • Chakrabarti S; Department of Biochemistry and Central Research Cell, Maharishi Markandeshwar University, Mullana, Haryana, India. Electronic address: profschakrabarti95@gmail.com.
  • Chakrabarti SS; Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India.
  • Chandan G; Department of Biochemistry and Central Research Cell, Maharishi Markandeshwar University, Mullana, Haryana, India.
  • Kaur U; Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India.
  • Agrawal BK; Department of Medicine, Maharishi Markandeshwar University, Mullana, Haryana, India.
Lancet Infect Dis ; 22(4): 446-447, 2022 04.
Article in En | MEDLINE | ID: mdl-35338863

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: ChAdOx1 nCoV-19 Limits: Humans Country/Region as subject: Asia Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: ChAdOx1 nCoV-19 Limits: Humans Country/Region as subject: Asia Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Document type: Article Country of publication: